S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom

Organigram (OGI) Stock Forecast & Price Target

C$2.53
-0.10 (-3.80%)
(As of 04/17/2024 ET)

Organigram Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

C$3.85
52.17% Upside
High ForecastC$5.25
Average ForecastC$3.85
Low ForecastC$2.70
TypeCurrent Forecast
4/19/23 to 4/18/24
1 Month Ago
3/20/23 to 3/19/24
3 Months Ago
1/19/23 to 1/19/24
1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$3.85C$3.80C$3.29C$1.69
Predicted Upside52.17% Upside86.18% Upside118.50% Upside56.73% Upside
Get Organigram Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

OGI Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OGI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Organigram Stock vs. The Competition

TypeOrganigramMedical Companies
Consensus Rating Score
2.67
2.68
Consensus RatingModerate BuyModerate Buy
News Sentiment RatingNeutral News
Neutral News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/3/2024ATB Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetOutperformC$5.25+76.77%
2/27/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuyC$4.95 ➝ C$4.40+52.78%
2/14/2024Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutralC$2.00 ➝ C$2.70+8.43%
12/20/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$4.00 ➝ C$3.75+123.21%
7/18/2023Haywood Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$5.00 ➝ C$3.00+60.43%
7/17/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$1.25 ➝ C$4.00+104.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:29 AM ET.

OGI Price Target - Frequently Asked Questions

What is Organigram's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Organigram stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for OGI. The average twelve-month price prediction for Organigram is C$3.85 with a high price target of C$5.25 and a low price target of C$2.70. Learn more on OGI's analyst rating history.

Do Wall Street analysts like Organigram more than its competitors?

Analysts like Organigram less than other Medical companies. The consensus rating score for Organigram is 2.67 while the average consensus rating score for medical companies is 2.68. Learn more on how OGI compares to other companies.

Does Organigram's stock price have much upside?

According to analysts, Organigram's stock has a predicted upside of 56.15% based on their 12-month stock forecasts.

What analysts cover Organigram?

Organigram has been rated by Alliance Global Partners, ATB Capital, and Jefferies Financial Group in the past 90 days.


Stock Ratings Reports and Tools

This page (TSE:OGI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners